Detection and clinical application of minimal residual disease in multiple myeloma / 国际肿瘤学杂志
Journal of International Oncology
; (12): 56-58, 2018.
Article
en Zh
| WPRIM
| ID: wpr-693443
Biblioteca responsable:
WPRO
ABSTRACT
Minimal residual disease (MRD) is a very important prognostic factor in multiple myeloma (MM).The major types of MRD tests include cell-based test (multi-parameter flow cytometry) and molecular tests (including PCR and gene sequencing),and the various techniques have inherent advantages and limitations.In clinical application,MRD negative can significantly prolong progression-free survival and overall survival of patients who receive hematopoietic stem cell transplantation and conventional che-motherapy.Moreover,the MRD status is of great significance to the selection of treatment options.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Idioma:
Zh
Revista:
Journal of International Oncology
Año:
2018
Tipo del documento:
Article